T2BLB_BACSQ
ID T2BLB_BACSQ Reviewed; 301 AA.
AC Q9LAI0;
DT 16-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT 01-OCT-2000, sequence version 1.
DT 25-MAY-2022, entry version 46.
DE RecName: Full=Type II restriction enzyme BslI subunit beta {ECO:0000303|PubMed:12654995};
DE Short=R.BslIbeta;
DE EC=3.1.21.4 {ECO:0000269|PubMed:10648519};
DE AltName: Full=Endonuclease BslI subunit beta;
DE AltName: Full=Type IIT restriction enzyme BslI subunit beta;
DE AltName: Full=Type-2 restriction enzyme BslI subunit beta;
GN Name=bslIRbeta {ECO:0000303|PubMed:10648519};
OS Bacillus sp. (strain NEB-606).
OC Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX NCBI_TaxID=114630;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF N-TERMINUS,
RP FUNCTION, AND SUBUNIT.
RX PubMed=10648519; DOI=10.1128/jb.182.4.949-955.2000;
RA Hsieh P.-C., Xiao J.-P., O'Loane D., Xu S.-Y.;
RT "Cloning, expression, and purification of a thermostable nonhomodimeric
RT restriction enzyme, BslI.";
RL J. Bacteriol. 182:949-955(2000).
RN [2]
RP ZINC-BINDING, ABSORPTION SPECTROSCOPY, AND MUTAGENESIS OF CYS-62; HIS-66;
RP CYS-79 AND CYS-82.
RC STRAIN=NEB-606;
RX PubMed=14623197; DOI=10.1016/j.jmb.2003.09.043;
RA Scheuring Vanamee E., Hsieh P.-C., Zhu Z., Yates D., Garman E., Xu S.-Y.,
RA Aggarwal A.K.;
RT "Glucocorticoid receptor-like Zn(Cys)4 motifs in BslI restriction
RT endonuclease.";
RL J. Mol. Biol. 334:595-603(2003).
RN [3]
RP NOMENCLATURE, AND SUBTYPE.
RX PubMed=12654995; DOI=10.1093/nar/gkg274;
RA Roberts R.J., Belfort M., Bestor T., Bhagwat A.S., Bickle T.A.,
RA Bitinaite J., Blumenthal R.M., Degtyarev S.K., Dryden D.T., Dybvig K.,
RA Firman K., Gromova E.S., Gumport R.I., Halford S.E., Hattman S.,
RA Heitman J., Hornby D.P., Janulaitis A., Jeltsch A., Josephsen J., Kiss A.,
RA Klaenhammer T.R., Kobayashi I., Kong H., Krueger D.H., Lacks S.,
RA Marinus M.G., Miyahara M., Morgan R.D., Murray N.E., Nagaraja V.,
RA Piekarowicz A., Pingoud A., Raleigh E., Rao D.N., Reich N., Repin V.E.,
RA Selker E.U., Shaw P.C., Stein D.C., Stoddard B.L., Szybalski W.,
RA Trautner T.A., Van Etten J.L., Vitor J.M., Wilson G.G., Xu S.Y.;
RT "A nomenclature for restriction enzymes, DNA methyltransferases, homing
RT endonucleases and their genes.";
RL Nucleic Acids Res. 31:1805-1812(2003).
CC -!- FUNCTION: A P subtype restriction enzyme that recognizes the double-
CC stranded sequence 5'-CCN(7)GG-3' and cleaves after N-7.
CC {ECO:0000269|PubMed:10648519, ECO:0000303|PubMed:12654995}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=Endonucleolytic cleavage of DNA to give specific double-
CC stranded fragments with terminal 5'-phosphates.; EC=3.1.21.4;
CC Evidence={ECO:0000269|PubMed:10648519};
CC -!- COFACTOR:
CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:14623197};
CC -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC Temperature dependence:
CC Is one of the thermostable restriction enzymes that remain active
CC after 20 to 30 cycles of thermal PCR cycling.;
CC -!- SUBUNIT: Heterotetramer of two alpha and two beta subunits. The alpha
CC subunit is believed to be responsible for DNA recognition, while the
CC beta subunit is thought to mediate cleavage.
CC {ECO:0000269|PubMed:10648519}.
CC -!- BIOTECHNOLOGY: Could be used to screen carcinogenic mutations in a
CC restriction endonuclease-mediated selective PCR (or REMS-PCR) assay. In
CC particular, could be used to detect the vast majority of mutations that
CC occur at codons 12 or 13 of the Ras oncogenes that encode glycine
CC (codons GGN) at those positions.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF135191; AAF32531.1; -; Genomic_DNA.
DR AlphaFoldDB; Q9LAI0; -.
DR REBASE; 386; BslI.
DR PRIDE; Q9LAI0; -.
DR PRO; PR:Q9LAI0; -.
DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR GO; GO:0009036; F:type II site-specific deoxyribonuclease activity; IEA:UniProtKB-EC.
DR GO; GO:0009307; P:DNA restriction-modification system; IEA:UniProtKB-KW.
PE 1: Evidence at protein level;
KW Direct protein sequencing; Endonuclease; Hydrolase; Metal-binding;
KW Nuclease; Restriction system; Zinc; Zinc-finger.
FT CHAIN 1..301
FT /note="Type II restriction enzyme BslI subunit beta"
FT /id="PRO_0000077284"
FT ZN_FING 62..82
FT /note="CHC2-type"
FT MUTAGEN 62
FT /note="C->K: Loss of activity."
FT /evidence="ECO:0000269|PubMed:14623197"
FT MUTAGEN 66
FT /note="H->K: 50% of wild-type activity."
FT /evidence="ECO:0000269|PubMed:14623197"
FT MUTAGEN 79
FT /note="C->K: 10% of wild-type activity."
FT /evidence="ECO:0000269|PubMed:14623197"
FT MUTAGEN 82
FT /note="C->K: 10% of wild-type activity."
FT /evidence="ECO:0000269|PubMed:14623197"
SQ SEQUENCE 301 AA; 35272 MW; 9EFAD4778F5E5A4C CRC64;
MEQQKFPNPR IFEDIDATDF SKHNKKHVTE DFVAENFKDV GWRVYRPFND TGIDLIAKKF
VCPDGHTKWN QNLTKEMTCS ECGKSLIEIT RFIQVKTREV KQVKTREAKG EKFFFGYTLK
SKDFRTDPRH VFLLYSDFTM DFIILPMYDY LNLFYTNQSL GSTHFSTPSF RQGNNKLNGL
SKDKNDNWVW SGVSFNEFVN EKGMDKLSCP IYDIELESYT KKIQELKFSL FYRYSPGRKN
QVSAPTVEFI NNHFSIFISL PKEAIASKRK AHLESLRQDL PEDLKKSVNE GYLVKFKGVD
L
